Ramsay Health Care Management
Management criteria checks 2/4
Ramsay Health Care's CEO is Natalie Davis, appointed in Oct 2024, has a tenure of less than a year. directly owns 0.021% of the company’s shares, worth A$1.75M. The average tenure of the management team and the board of directors is 3.3 years and 5.7 years respectively.
Key information
Natalie Davis
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | less than a year |
| CEO ownership | 0.02% |
| Management average tenure | 3.3yrs |
| Board average tenure | 5.7yrs |
Recent management updates
Recent updates
Why Investors Shouldn't Be Surprised By Ramsay Health Care Limited's (ASX:RHC) Low P/S
May 17
Ramsay Health Care (ASX:RHC) Could Be Struggling To Allocate Capital
Apr 29Is Ramsay Health Care (ASX:RHC) A Risky Investment?
Mar 23Ramsay Health Care's (ASX:RHC) Soft Earnings Don't Show The Whole Picture
Mar 05Ramsay Health Care (ASX:RHC) Has Affirmed Its Dividend Of A$0.40
Mar 02
Disciplined Investments And Digital Focus Will Drive Future Operating Efficiency
Disciplined transformation investments and engagement with payers could boost revenue, net margins, and earnings through enhanced productivity and better tariff indexation.Ramsay Health Care Limited (ASX:RHC) Not Flying Under The Radar
Jan 10Returns On Capital At Ramsay Health Care (ASX:RHC) Paint A Concerning Picture
Nov 11Here's Why Ramsay Health Care (ASX:RHC) Has A Meaningful Debt Burden
Oct 06Why Investors Shouldn't Be Surprised By Ramsay Health Care Limited's (ASX:RHC) P/E
Sep 18Ramsay Health Care (ASX:RHC) May Have Issues Allocating Its Capital
Jul 12Ramsay Health Care Limited's (ASX:RHC) Intrinsic Value Is Potentially 54% Above Its Share Price
Jun 24Shareholders Should Be Pleased With Ramsay Health Care Limited's (ASX:RHC) Price
Jun 06CEO
Natalie Davis
Ms. Natalie Davis is Director of Ramsay Health Care Limited from December 2, 2024 and its Managing Director and Chief Executive Officer since October 2024. Ms. Davis had been Managing Director of Supermark...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| MD, Group CEO & Director | less than a year | no data | 0.021% A$ 1.7m | |
| Chief Financial Officer | 1.8yrs | no data | no data | |
| Group Head of Investor Relations | no data | no data | no data | |
| Group General Counsel & Company Secretary | 5.9yrs | no data | no data | |
| Group Chief People Officer | no data | no data | no data | |
| Group Chief Risk Officer | no data | no data | no data | |
| Group Chief Transformation & Digital Officer | 3.4yrs | no data | no data | |
| Chief Health & Strategy Officer | less than a year | no data | no data | |
| Chief Executive Officer of Ramsay Australia | 5.3yrs | no data | no data | |
| CEO of Ramsay Générale De Santé | no data | no data | no data | |
| Chief Executive Officer of Ramsay UK | 3.3yrs | no data | no data |
Experienced Management: RHC's management team is considered experienced (3.3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| MD, Group CEO & Director | less than a year | no data | 0.021% A$ 1.7m | |
| Independent Non-Executive Director | 50yrs | AU$430.56k | 1.7% A$ 141.3m | |
| Independent Chairman of the Board | 7.5yrs | AU$502.51k | 0.0076% A$ 634.3k | |
| Independent Non-Executive Director | 3.5yrs | AU$298.76k | 0.0023% A$ 192.9k | |
| Independent Non-Executive Director | 6.5yrs | AU$291.42k | 0.0025% A$ 206.2k | |
| Independent Non-Executive Director | 1.2yrs | AU$91.90k | 0.0025% A$ 210.3k | |
| Independent Non-Executive Director | 5.2yrs | AU$312.50k | 0.0023% A$ 192.9k | |
| Independent Non-Executive Director | 5.7yrs | AU$275.70k | 0.0022% A$ 179.6k | |
| Independent Non-Executive Director | 6.6yrs | AU$292.56k | 0.0027% A$ 224.4k |
Experienced Board: RHC's board of directors are considered experienced (5.7 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/30 09:13 |
| End of Day Share Price | 2025/05/30 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Ramsay Health Care Limited is covered by 33 analysts. 15 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| John Hester | ANZ Equities Pty Limited |
| Saul Hadassin | Barrenjoey Markets Pty Limited |
| Lyanne Harrison | BofA Global Research |